2. Cardiovascular system
2.3. Anti-arrhythmic drugs
2.3.2. Drugs for arrhythmias
Total Formulary
AMIODARONE
Prescribing Notes:
Please note MHRA advice (March 2022) on continued need for patient supervision and regular review during treatment due to serious and potentially life-threatening side affects.
DRONEDARONE
Restrictions:
Restricted to patients for the prevention of recurrence of AF in patients in whom beta-blockers, class 1c drugs and amiodarone are contraindicated, ineffective or not tolerated and who do not have a diagnosis of heart failure.
MEXILETINE cardiac (capsules)
VERAPAMIL